Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Finch Therapeutics Group Inc (FNCH)

Finch Therapeutics Group Inc (FNCH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Finch Therapeutics Group Inc 75 State Street Suite 100 Boston MA 02109 USA

www.finchtherapeutics.com Employees: 1 P: 617-229-6499

Description:

Finch Therapeutics Group Inc. is a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery(R) platform to develop a novel class of orally administered biological drugs. The company's product candidate includes CP101, FIN-211, FIN-524 and FIN-525. Finch Therapeutics Group Inc. is based in SOMERVILLE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 19,351
Enterprise Value, $K -5,769
Shares Outstanding, K 1,606
Annual Sales, $ 110 K
Annual Net Income, $ -74,750 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -4,830 K
EBIT, $ -17,910 K
EBITDA, $ -16,390 K
60-Month Beta 1.34
% of Insider Shareholders 44.90%
% of Institutional Shareholders 21.77%
Float, K 885
% Float 55.10%
Short Volume Ratio 0.43

Growth:

1-Year Return 180.26%
3-Year Return -96.71%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -3.01 on 08/13/24
Next Earnings Date 11/13/24
Earnings Per Share ttm -8.82
EPS Growth vs. Prev Qtr -24.90%
EPS Growth vs. Prev Year 30.48%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 06/12/23

FNCH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -69.14%
Return-on-Assets % -26.92%
Profit Margin % -67,954.55%
Debt/Equity 0.00
Price/Sales 180.84
Price/Cash Flow N/A
Price/Book 1.36
Book Value/Share 8.83
Interest Coverage -0.02
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar